JP2010508249A5 - - Google Patents

Download PDF

Info

Publication number
JP2010508249A5
JP2010508249A5 JP2009533741A JP2009533741A JP2010508249A5 JP 2010508249 A5 JP2010508249 A5 JP 2010508249A5 JP 2009533741 A JP2009533741 A JP 2009533741A JP 2009533741 A JP2009533741 A JP 2009533741A JP 2010508249 A5 JP2010508249 A5 JP 2010508249A5
Authority
JP
Japan
Prior art keywords
acid
sodium
preparation according
preparation
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009533741A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010508249A (ja
JP5590889B2 (ja
Filing date
Publication date
Priority claimed from DE102006050931A external-priority patent/DE102006050931A1/de
Application filed filed Critical
Publication of JP2010508249A publication Critical patent/JP2010508249A/ja
Publication of JP2010508249A5 publication Critical patent/JP2010508249A5/ja
Application granted granted Critical
Publication of JP5590889B2 publication Critical patent/JP5590889B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009533741A 2006-10-28 2007-10-26 クレアチン成分を含有する固形の又は水性のアルカリ性調製物、その製造方法及びその使用 Expired - Fee Related JP5590889B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006050931.5 2006-10-28
DE102006050931A DE102006050931A1 (de) 2006-10-28 2006-10-28 Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
PCT/EP2007/009324 WO2008052712A1 (de) 2006-10-28 2007-10-26 Feste oder wässrige alkalische zubereitung umfassend eine kreatin-komponente, verfahren zu deren herstellung und ihre verwendung

Publications (3)

Publication Number Publication Date
JP2010508249A JP2010508249A (ja) 2010-03-18
JP2010508249A5 true JP2010508249A5 (enExample) 2010-12-16
JP5590889B2 JP5590889B2 (ja) 2014-09-17

Family

ID=38980980

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009533741A Expired - Fee Related JP5590889B2 (ja) 2006-10-28 2007-10-26 クレアチン成分を含有する固形の又は水性のアルカリ性調製物、その製造方法及びその使用

Country Status (11)

Country Link
US (1) US20100056633A1 (enExample)
EP (1) EP2094116B1 (enExample)
JP (1) JP5590889B2 (enExample)
AT (1) ATE468030T1 (enExample)
CA (1) CA2667667C (enExample)
DE (2) DE102006050931A1 (enExample)
DK (1) DK2094116T3 (enExample)
ES (1) ES2341910T3 (enExample)
PL (1) PL2094116T3 (enExample)
SI (1) SI2094116T1 (enExample)
WO (1) WO2008052712A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
DE102007062288A1 (de) 2007-12-21 2009-06-25 Alzchem Trostberg Gmbh Kreatin-Zubereitung und Verfahren zu deren Herstellung
EP2653161B1 (en) 2008-12-30 2015-10-07 Hill's Pet Nutrition, Inc. Use of lipoic acid for maintaining or increasing bone mineral density in companion animals
PL2416770T3 (pl) 2009-04-06 2017-06-30 Crearene Ltd. Roztwory do hemodializy i dializy otrzewnowej zawierające jeden lub więcej związków kreatyny
US10449157B2 (en) 2013-06-12 2019-10-22 Anabio Technologies Limited Process for producing microcapsules comprising an active component encapsulated, protected and stabilised within a protein shell
JP6991445B2 (ja) * 2016-09-06 2022-02-03 地方独立行政法人青森県産業技術センター アルギニンを豊富に含有する多糖

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322407A (en) * 1978-12-11 1982-03-30 Vitapharm Pharmaceutical Pty. Ltd. Electrolyte drink
US5151274A (en) * 1990-08-06 1992-09-29 The Procter & Gamble Company Calcium and trace mineral supplements
US5318784A (en) * 1992-09-09 1994-06-07 Amurol Products Company Pourable chewing gum and confection composition
US5908864A (en) * 1998-05-28 1999-06-01 Dymatize Enterprises Creatine gel
DE19830768A1 (de) * 1998-07-09 2000-01-13 Sueddeutsche Kalkstickstoff Kreatin-enthaltende Formulierung und Verfahren zu deren Herstellung
US6136339A (en) * 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6242491B1 (en) * 1999-06-25 2001-06-05 Rima Kaddurah-Daouk Use of creatine or creatine compounds for skin preservation
US6114379A (en) * 1999-07-07 2000-09-05 Albion Laboratories, Inc. Bioavailable chelates of creatine and essential metals
WO2001089476A1 (en) * 2000-05-19 2001-11-29 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US6399661B1 (en) * 2000-06-26 2002-06-04 Jeffrey M. Golini Oral creatine supplement and method for making same
EP1363509B1 (en) * 2001-03-02 2006-10-11 The Howard Foundation Compositions containing creatine and creatinine
DE10215007A1 (de) * 2002-04-05 2003-10-16 Degussa Bioactives Deutschland Verwendung von Kreatinpyruvat zur Steigerung der Ausdauer bei hochintensiven körperlichen Intervallbelastungen
US7067150B2 (en) * 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
US7238373B2 (en) * 2003-04-04 2007-07-03 Nutritox Llc Nutritional supplement
GB0323240D0 (en) * 2003-10-03 2003-11-05 Golini Jeffrey M Creatine composition and use
SI1758463T1 (sl) * 2004-06-09 2008-08-31 Alzchem Trostberg Gmbh Gvanidino ocetna kislina kot dodatek Ĺľivalski hrani
US20080003208A1 (en) * 2006-05-11 2008-01-03 Avicena Froup, Inc. Creatine-ligand compounds and methods of use thereof

Similar Documents

Publication Publication Date Title
US7772428B2 (en) Creatine hydroxycitric acids salts and methods for their production and use in individuals
JP2010508249A5 (enExample)
JP2010521420A5 (enExample)
JP2006510711A5 (enExample)
JP2018505191A (ja) 腎不全患者治療のためのカルボン酸混合物
AU2006220005B2 (en) Salts, addition compounds and complex compounds of guanidinoacetic acid
JP2011088838A (ja) アルギニン及びカルニチン含有錠剤の製造方法
US20090312419A1 (en) CREATINE -ßALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE
JP2008531029A5 (enExample)
JP5290975B2 (ja) L−カルニチンフマル酸カルシウム及びその製造方法と用途
JP2009503003A5 (enExample)
US20130096193A1 (en) Creatine beta-alaninate: a novel salt for increasing athletic performance
US8536222B2 (en) Addition compounds of guanidinoacetic acid
JP5467751B2 (ja) タンパク質凝固作用が抑制されてなるアミノ酸含有固体組成物
JP7394076B2 (ja) 分岐鎖ケト酸(bcka)の混合物の製造方法
ITRM20000567A1 (it) Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine con l'
TWI328427B (en) Chitosan-containing powder
KR102883369B1 (ko) 아르기닌을 활용한 건강기능식품 조성물 및 이의 제조방법
EP1530463B1 (en) L-arginine containing pharmaceutical composition
US20080153897A1 (en) Creatine pyroglutamic acid salts and methods for their production and use in individuals
UA141452U (uk) Дієтична добавка
US20080234372A1 (en) Creatine Salt with Enhanced Nutritional and Therapeutic Efficacy and Compositions Containing Same
ZA200300639B (en) Pharmaceuticals and nutritional supplements.
WO2009079739A1 (en) The use of creatine pyroglutamicacid salt to facilitate increased neural health
BR102013016963A2 (pt) Composto de lisina, uso de um composto de lisina, processo de facilitação de aproveitamento de dietas de animais, processo para adição de lisina em rações, ração animal, composição alimentícia e farmacêutica veterinárias e método para o tratamento de animais